These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 16209338)

  • 1. [The mechanisms of hepatitis C virus resistance to interferon].
    Kmieciak D
    Postepy Biochem; 2005; 51(1):22-7. PubMed ID: 16209338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.
    Shih JW; Tsai TY; Chao CH; Wu Lee YH
    Oncogene; 2008 Jan; 27(5):700-14. PubMed ID: 17667941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of host protein synthesis in B95a cells infected with the HL strain of measles virus.
    Inoue Y; Tsukiyama-Kohara K; Yoneda M; Sato H; Kai C
    Comp Immunol Microbiol Infect Dis; 2009 Jan; 32(1):29-41. PubMed ID: 18930544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mammalian translation initiation by volatile anesthetics.
    Palmer LK; Rannels SL; Kimball SR; Jefferson LS; Keil RL
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1267-75. PubMed ID: 16434554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2.
    Terenin IM; Dmitriev SE; Andreev DE; Shatsky IN
    Nat Struct Mol Biol; 2008 Aug; 15(8):836-41. PubMed ID: 18604219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potyvirus terminal protein VPg, effector of host eukaryotic initiation factor eIF4E.
    Grzela R; Strokovska L; Andrieu JP; Dublet B; Zagorski W; Chroboczek J
    Biochimie; 2006 Jul; 88(7):887-96. PubMed ID: 16626853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.
    Eley HL; Russell ST; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1409-16. PubMed ID: 18854427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Atlantic salmon Z-DNA binding protein kinase phosphorylates translation initiation factor 2 alpha and constitutes a unique orthologue to the mammalian dsRNA-activated protein kinase R.
    Bergan V; Jagus R; Lauksund S; Kileng Ø; Robertsen B
    FEBS J; 2008 Jan; 275(1):184-97. PubMed ID: 18076653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK1/2 map kinase metabolic pathway is responsible for phosphorylation of translation initiation factor eIF4E during in vitro maturation of pig oocytes.
    Ellederová Z; Cais O; Susor A; Uhlírová K; Kovárová H; Jelínková L; Tomek W; Kubelka M
    Mol Reprod Dev; 2008 Feb; 75(2):309-17. PubMed ID: 17290414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus, the E2 envelope protein, and alpha-interferon resistance.
    Abid K; Quadri R; Negro F
    Science; 2000 Mar; 287(5458):1555. PubMed ID: 10733410
    [No Abstract]   [Full Text] [Related]  

  • 12. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
    Vary TC; Lynch CJ
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E631-42. PubMed ID: 16263769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual regulation of translation initiation and peptide chain elongation during BDNF-induced LTP in vivo: evidence for compartment-specific translation control.
    Kanhema T; Dagestad G; Panja D; Tiron A; Messaoudi E; Håvik B; Ying SW; Nairn AC; Sonenberg N; Bramham CR
    J Neurochem; 2006 Dec; 99(5):1328-37. PubMed ID: 17064361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms on interferon resistance of hepatitis C virus].
    Naka K; Kato N
    Tanpakushitsu Kakusan Koso; 2004 Mar; 49(4):526-33. PubMed ID: 15024843
    [No Abstract]   [Full Text] [Related]  

  • 15. Translational insensitivity to potent activation of PKR by HCV IRES RNA.
    Shimoike T; McKenna SA; Lindhout DA; Puglisi JD
    Antiviral Res; 2009 Sep; 83(3):228-37. PubMed ID: 19467267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide mediates NMDA-induced persistent inhibition of protein synthesis through dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 and eukaryotic initiation factor 4G proteolysis.
    Petegnief V; Font-Nieves M; Martín ME; Salinas M; Planas AM
    Biochem J; 2008 May; 411(3):667-77. PubMed ID: 18215131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potyviral virus genome-linked protein VPg forms a ternary complex with the eukaryotic initiation factors eIF4E and eIF4G and reduces eIF4E affinity for a mRNA cap analogue.
    Michon T; Estevez Y; Walter J; German-Retana S; Le Gall O
    FEBS J; 2006 Mar; 273(6):1312-22. PubMed ID: 16519694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
    Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
    J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.